Monika Konaklieva Associate Professor CAS | CHEM | Chemistry

Degrees: PhD, Organic Chemistry, State University of New York at Buffalo<br>MS, Chemistry, Institute of Organic Chemistry, Sofia, Bulgaria<br>MS, Pharmacy, State University Medical Academy, Sofia, Bulgaria
Bio: Dr. Konaklieva’s research is in the area of exploring different approaches for delaying of microbial resistance. Current projects include computer-aided design and synthesis of novel beta-lactams as well as development of synthetic methodology for preparation of
other “non-conventional” candidates as beta-lactamase and Human Leukocyte Elastase inhibitors.

See Also: Chemistry Department
For the Media: To request an interview for a news story, call AU Communications at 202-885-5950 or submit a request.; AU Experts

Teaching

NIST-Sponsored Undergraduate Student Summer Fellowship (2003)
NIST-Sponsored Undergraduate Student Summer Fellowship (2002)
The Research Corporation, Beta-Lactamase activated NO-containing beta-lactams (2002)

Monika I. Konaklieva and Balbina J. Plotkin, “Bioisosters of Beta-Lactams as Anti-Infectives" Current Medicinal Chemistry Anti-Infective Agents, 2,4 (2003)
Timothy E. Long; Edward Turos; Monika I. Konaklieva; Allison L. Blum; Amal Amry;Ejae A. Baker; Lita S. Suwandi; Melodie D. McCain; Miti F. Rahman; Sonja Dickey;Daniel V. Lim, “Effect of Aryl Ring Fluorination on the Antibacterial Properties of C4 Aryl- Substituted N-Methylthio beta- Lactams” Bioorganic & Medicinal Chemistry, 11,1859, (2003)
Jeffrey R. Deschamps., Lita Suwandi, and Monika Konaklieva, “3,3-Bis(methylthio)-2-oxo-N-phenylpropanamide”Acta Crystallographica Section E, Structure Reports, E59, 1,(2003)